More than meets the eye by Sample, Susan & Nelson, Brad
 [ Table of Contents | Next Article ]
More Than Meets the Eye
Images of a Research Lab
Text by Susan Sample
Photos by Brad Nelson
(Following is the text of the essay. To view the photos, please request a printed copy of
the magazine from the Table of Contents page.)
 
If you depend only upon your eyes, you won't see what's really going on in a
research lab-even in the Department of Ophthalmology and Visual Sciences,
where the focus is on understanding vision.
"You don't really see with the eye," said Jennifer S. Lund, Ph.D., professor of
ophthalmology at the University's John A. Moran Eye Center. "What we see is
actually due to the activity of cells in the cerebral cortex, which are stacked like
a three-dimensional mosaic with interplay via the feedforward and feedback
relays between many cortical areas."
Light rays pass through the cornea and the pupil to the lens, which focuses the
rays on the retina. There, light is transformed into electrical impulses, then sent
through the optic nerve to the brain, where the image actually is recognized.
A laboratory can be just as complex. Everyone recognizes rooms lined with
shelves of beakers and benches with microscopes. But to know the creativity
and the drudgery, the loneliness as well as the exhilaration of "eureka" moments
that make all of the effort worthwhile, you must piece together images and
impressions.
"Each neuron in the retina sees a little bit of the outside world," said Lund, who
is developing a wiring diagram to explain the visual functions of the cerebral
cortex. "The neurons take these messages to the brain, first the thalamus, then
the cerebral cortex, where there are millions of neurons elaborately wired
together like a vast computer-better than anything man can build. We're quite a
long way from understanding it all."
Lund's research, among the most basic science investigations at the medical
school's comprehensive eye center, still is linked to vision problems for which
patients are seen in the clinics one floor above her lab. "With some diseases,
you fail to see motion, or you see only half of the visual scheme or no colors,"
said Lund. "That's because of defects in the cerebral cortex."
"We all work together toward one end," noted Jill Church-Kopish, a lab
specialist in the department's Cell and Molecular Biology Lab. "You work
closer with people in a lab. It becomes like a family.
"It's not like I do the same thing every day," explained the Michigan native, who
taught high school there and in Park City. "It keeps changing. I like being on the
front edge of change, too."
She doesn't always like the pressure, though. "Deadlines," she said, shaking her
head. "Researchers want experiments to get done right away-ASAP-so they
won't get scooped. You have to roll with the pressure." Or, as Church-Kopish
has done, resort to humor. Embroidered on her lab coat is a patch with Dexter, a
Cartoon Network character who has a secret lab in his parents' house.
Miniatures of Dexter and his spaceship sit atop her computer screen.
"You have to have a sense of humor," said Edward M. Levine, Ph.D., assistant
professor of ophthalmology and visual sciences, whose lab is housed in the
Eccles Institute of Human Genetics. "Things don't always work out on time and
the way you plan. If you take everything seriously that goes wrong, you'll go
crazy."
Appropriate attire-shorts, tee shirts, sandals, anything casual-also is important.
"People have to be comfortable. This work isn't a list of assignments," said the
researcher who studies the pathways of retinal development using transgenic
and knockout mice. "It will stifle creativity if the lab's too structured."
Across the hall is the lab of Rajendra Kumar-Singh, Ph.D., where gene therapy
for retinitis pigmentosa, one of the most common genetic causes of blindness in
the United States, is being investigated. He is using cold viruses to deliver
therapeutic DNA into diseased tissues. "The culture of a lab is very surreal.
Everything happens in a test tube. As a scientist, you're like an enzyme in the
tube," mused the assistant professor.
"Over here is a restriction enzyme in a little tube: a molecule that does
wonderful things. But it's only theory. You can't see it, because it's at the
molecular level. So you do your experiment in theory. It's a leap of faith. If it
works out, then you see it.
"Scientists spend a lot of time in lonely environments," said Kumar-Singh. "But
you could come in the lab and be the first one on the planet to see, to
understand a concept. The first ever, ever, because you discovered it.
"Occasionally, there is drudgery," he acknowledged, "but there are different
kinds." A 1994 graduate of the University of Dublin, Ireland, Kumar-Singh can
recall vividly his student years in labs: "graduate students and postdocs are still
paid buttons for the amount of work they do." Now the drudgery has evolved to
writing grants for his own lab. The difference is in the amount of control he has.
"As a research scientist, you can explore more things. You can follow the clues
in the way you want to. You know Robert Frost's poem 'The Road Not Taken'?
You can take that road. In how many jobs can you do that? It's a wonderful
job."
"It was a lot of fun in the lab," agreed Wolfgang Baehr, Ph.D., professor and
director of the department's Wynn Center for the Study of Retinal Degeneration,
who started out as an organic chemist in Germany. "I did it for 30 years. That's
enough. I still do analyzing and sequencing gels, but I hire people to do
pipetting.
"Since I'm a senior guy, I do fundraising. Writing papers is my major
occupation," noted Baehr, whose lab is working to identify genes that cause
retinal degeneration and understand how gene mutations produce disease. "If
you don't publish papers, you don't get funded. If you don't get funded, you're
out of business-no matter how smart you are."
The author of more than 400 publications, Raymond D. Lund, Ph.D., is
intimately familiar with administrative responsibilities. He served as a
department chair for 15 years-including three at Cambridge University in
England-before joining Utah's medical school as a researcher last fall. "The
problem is administration has become a full-time job these days," said Lund. "I
sidestepped back into science.
"I thought why not? It's like being a kid again," he said with a characteristic
laugh. But he had another reason, too. "It's really corny. I'm the vice chair of the
scientific committee of the Foundation Fighting Blindness. I kept going to these
meetings and seeing people going blind, and I thought: what am I doing in
administration?"
Lund is studying retinal cell transplantation that, someday, may prevent
deterioration caused by retinitis pigmentosa, macular degeneration and other
retinal diseases, which lead to blindness. He's devised ways to map the visual
field by exposing rats-in which retinitis pigmentosa was first discovered-to light
signals, then recording the electrical activity in their brains before and after
receiving retinal transplants. The tests, which mimic those of human patients,
are helping researchers determine how disease is distributed across the retina
before transplantation and evaluate the effectiveness of treatment.
"We pick up what other researchers like Ed and Rajendra are doing, and apply it
to animal models to see how it can help people. There's a kind of synergy in
putting all these parts together," said Lund.
"When we started studying how the brain is put together and what happens
when it's damaged, we had no linkage to anything conceivably clinical. But the
culture of the lab has changed from basic research-trying to do experiments that
provide scientific solutions-to experiments that provide clinical outcomes.
We're trying to bridge that gap.
"It's a major change in the way we do business," noted the British investigator.
"It's quite interesting."
Even the department's most futuristic project, an artificial vision system being
developed by Richard A. Normann, Ph.D., has a clinical application in sight.
"Eventually, we'll implant six to seven microelectrode arrays in the visual
cortex of a blind person," said Normann, professor of ophthalmology and
bioengineering who directs the Moran Laboratories for Applied Vision and
Neural Sciences.
Each silicon array measures four millimeters by four millimeters and contains
100 electrodes. The patient will wear glasses embedded with a miniature
television camera in the nosepiece, which will pick up video signals. These will
be changed by a signal processor into a set of stimulus signals, which will be
sent to the electrode arrays implanted in the brain. The electrodes will thereby
excite specific neurons.
"We will remap visual space into an appropriate two-dimensional array of
electrical signals," said Normann. "It's got a way to go. We're working on other
parts of the puzzle. For instance, how close can the electrodes be and still
produce two distinct points of light?"
Normann's lab has a synergy of its own with ideas coming from bioengineering,
materials science, electrical and mechanical engineering, and applied
neuroscience. Yet the researcher sees this creativity distinct from the physical
space.
"I think of the lab more as a work environment. There is no special environment
where you go to create ideas. They come when you're driving, when you're in
the shower. You're not going to have those ideas unless you work hard and
immerse yourself in your problem.
"One of the great things about academic labs is you get to work with students,"
added Normann. "Trying to explain yourself to students makes you think why
you're doing something and how you could do it better."
When the subject is artificial vision, the researcher frequently has to explain
how real science differs from Hollywood's version. In the movie The Matrix,
for instance, people received computer brain transplants and were plugged into
a virtual world. "A lot of the students who come into the lab have fantasies of
doing that. We try to channel their actions into real-world problems."
But not the fascination and curiosity that are essential to any successful lab.
"Curiosity," said Normann, leaning back in his chair, "is the motivation for
what goes on here."
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